Aclarubicin
Aclarubicin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Aclidinium
Aclidinium may increase the anticholinergic activities of Botulinum Toxin Type A.
Amikacin
Amikacin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Advertisement
Arbekacin
Arbekacin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Atracurium
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Atracurium.
Atracurium Besylate
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Atracurium besylate.
Advertisement
Atropine
Atropine may increase the anticholinergic activities of Botulinum Toxin Type A.
Benactyzine
Benactyzine may increase the anticholinergic activities of Botulinum Toxin Type A.
Benztropine
Benzatropine may increase the anticholinergic activities of Botulinum Toxin Type A.
Advertisement
Biperiden
Biperiden may increase the anticholinergic activities of Botulinum Toxin Type A.
Butylscopolamine
Butylscopolamine may increase the anticholinergic activities of Botulinum Toxin Type A.
Chlorphenoxamine
Chlorphenoxamine may increase the anticholinergic activities of Botulinum Toxin Type A.
Cisatracurium
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Cisatracurium besylate.
Cyclopentolate
Cyclopentolate may increase the anticholinergic activities of Botulinum Toxin Type A.
Darifenacin
Darifenacin may increase the anticholinergic activities of Botulinum Toxin Type A.
Daunorubicin
Daunorubicin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Desloratadine
Desloratadine may increase the anticholinergic activities of Botulinum Toxin Type A.
Dexetimide
Dexetimide may increase the anticholinergic activities of Botulinum Toxin Type A.
Dicyclomine
Dicyclomine may increase the anticholinergic activities of Botulinum Toxin Type A.
Dihydrostreptomycin
Dihydrostreptomycin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Doxacurium Chloride
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Doxacurium chloride.
Doxorubicin
Doxorubicin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Doxorubicin Hydrochloride
Doxorubicin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Epirubicin
Epirubicin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Fesoterodine
Fesoterodine may increase the anticholinergic activities of Botulinum Toxin Type A.
Framycetin
Framycetin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Gallamine Triethiodide
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Gallamine Triethiodide.
Gentamicin
Gentamicin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Glycopyrronium
Glycopyrronium may increase the anticholinergic activities of Botulinum Toxin Type A.
Homatropine
Homatropine may increase the anticholinergic activities of Botulinum Toxin Type A.
Hyoscyamine
Hyoscyamine may increase the anticholinergic activities of Botulinum Toxin Type A.
Idarubicin
Idarubicin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Ipratropium Bromide
Ipratropium bromide may increase the anticholinergic activities of Botulinum Toxin Type A.
Ipratropium Bromide Anhydrous
Ipratropium bromide may increase the anticholinergic activities of Botulinum Toxin Type A.
Kanamycin
Kanamycin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
kanamycin A
Kanamycin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Mecamylamine
Mecamylamine may increase the anticholinergic activities of Botulinum Toxin Type A.
Methantheline
Methantheline may increase the anticholinergic activities of Botulinum Toxin Type A.
Methixene
Metixene may increase the anticholinergic activities of Botulinum Toxin Type A.
Methscopolamine
Methscopolamine may increase the anticholinergic activities of Botulinum Toxin Type A.
Methscopolamine Bromide
Methylscopolamine bromide may increase the anticholinergic activities of Botulinum Toxin Type A.
Metocurine
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Metocurine.
Metocurine iodide
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Metocurine Iodide.
Metrizamide
Metrizamide may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Mivacurium
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Mivacurium.
Neomycin
Neomycin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Netilmicin
Netilmicin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Octotropine Methylbromide
Anisotropine Methylbromide may increase the anticholinergic activities of Botulinum Toxin Type A.
Octylonium
Otilonium may increase the anticholinergic activities of Botulinum Toxin Type A.
Orphenadrine
Orphenadrine may increase the anticholinergic activities of Botulinum Toxin Type A.
Oxitropium
Oxitropium may increase the anticholinergic activities of Botulinum Toxin Type A.
Oxybutynin
Oxybutynin may increase the anticholinergic activities of Botulinum Toxin Type A.
Oxyphenonium
Oxyphenonium may increase the anticholinergic activities of Botulinum Toxin Type A.
Pancuronium
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Pancuronium.
Pancuronium Bromide
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Pancuronium.
Paromomycin
Paromomycin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Pipecuronium
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Pipecuronium.
Pirarubicin
Pirarubicin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Pirenzepine
Pirenzepine may increase the anticholinergic activities of Botulinum Toxin Type A.
Plicamycin
Plicamycin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Procyclidine
Procyclidine may increase the anticholinergic activities of Botulinum Toxin Type A.
Profenamine
Ethopropazine may increase the anticholinergic activities of Botulinum Toxin Type A.
Propantheline
Propantheline may increase the anticholinergic activities of Botulinum Toxin Type A.
Propantheline Bromide
Propantheline may increase the anticholinergic activities of Botulinum Toxin Type A.
Propiverine
Propiverine may increase the anticholinergic activities of Botulinum Toxin Type A.
Pyrantel
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Pyrantel.
Quinidine
Quinidine may increase the anticholinergic activities of Botulinum Toxin Type A.
Rapacuronium
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Rapacuronium.
rimabotulinumtoxinB
Botulinum Toxin Type A may increase the adverse neuromuscular activities of Botulinum Toxin Type B.
Rocuronium
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Rocuronium.
Scopolamine
Scopolamine may increase the anticholinergic activities of Botulinum Toxin Type A.
Scopolamine Hydrobromide
Scopolamine may increase the anticholinergic activities of Botulinum Toxin Type A.
Sisomicin
Sisomicin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Solifenacin
Solifenacin may increase the anticholinergic activities of Botulinum Toxin Type A.
Spectinomycin
Spectinomycin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Streptomycin
Streptomycin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Streptozocin
Streptozocin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Succinylcholine
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Succinylcholine.
Tiotropium
Tiotropium may increase the anticholinergic activities of Botulinum Toxin Type A.
Tobramycin
Tobramycin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Tolterodine
Tolterodine may increase the anticholinergic activities of Botulinum Toxin Type A.
Trihexyphenidyl
Trihexyphenidyl may increase the anticholinergic activities of Botulinum Toxin Type A.
Trihexyphenidyl Hydrochloride
Trihexyphenidyl may increase the anticholinergic activities of Botulinum Toxin Type A.
Trimethaphan
Trimethaphan may increase the anticholinergic activities of Botulinum Toxin Type A.
Tropicamide
Tropicamide may increase the anticholinergic activities of Botulinum Toxin Type A.
Trospium
Trospium may increase the anticholinergic activities of Botulinum Toxin Type A.
Tubocurarine
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Tubocurarine.
Umeclidinium
Umeclidinium may increase the anticholinergic activities of Botulinum Toxin Type A.
Valrubicin
Valrubicin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.
Vecuronium
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Vecuronium.
